Sol-Gel Technologies (SLGL) to Release Quarterly Earnings on Wednesday

Sol-Gel Technologies (NASDAQ:SLGL) will likely be issuing its quarterly earnings data before the market opens on Wednesday, March 12th. Analysts expect the company to announce earnings of ($0.11) per share and revenue of $2.00 million for the quarter.

Sol-Gel Technologies Price Performance

Shares of Sol-Gel Technologies stock opened at $0.57 on Tuesday. The stock has a market cap of $15.74 million, a price-to-earnings ratio of -1.66 and a beta of 1.29. The firm’s 50-day moving average is $0.82 and its 200 day moving average is $0.70. Sol-Gel Technologies has a 1 year low of $0.33 and a 1 year high of $1.65.

About Sol-Gel Technologies

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.